IP Verse

Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of Complement

Patent No. EP3167888 (titled "Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of Complement") was filed by Alexion Pharmaceuticals on Mar 15, 2007. The application was issued on May 1, 2024.

Patent Summary

UPC Cases New

Latest UPC cases involving this patent.

Case NumberFiling DatePlaintiffProceeding Type
UPC_COA_0000153/2026Sep 15, 2026Carpmaels & RansfordGeneric
UPC_COA_0000152/2026Sep 15, 2026Carpmaels & RansfordGeneric
UPC_CFI_674/2025Jul 22, 2025Samsung Bioepis NLGeneric
UPC_CFI_51/2025Jan 23, 2025Samsung Bioepis NLGeneric
UPC_CFI_40/2025Jan 22, 2025Samsung Bioepis NLGeneric
APP_3053/2025Jan 21, 2025AmgenGeneric
APP_60271/2024Nov 8, 2024Name NOT Displayed FOR Gdpr Reasons Represented BY Jochen Hohfeld, Redacted Natural Person NameGeneric
UPC_CFI_642/2024Oct 31, 2024Amgen Switzerland Vilniaus FilialasRevocation
APP_43687/2024Jul 29, 2024Amgen Technology Ireland UnlimitedGeneric
APP_43786/2024Jul 26, 2024Samsung Bioepis NLGeneric

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
SALUTE HC ILAC PAZARLAMAJan 31, 2025GRUNECKER PATENT
AMGEN TECHNOLOGY IRELAND UNLIMITEDOct 28, 2024DORRIES
AMGEN TECHNOLOGY IRELAND UNLIMITEDOct 28, 2024DORRIES, HANS ULRICH , DF-MP DORRIES FRANK-MOLNIA & POHLMAN
SAMSUNG BIOEPISMay 2, 2024SIMMONS & SIMMONS MUNICH

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP3167888

ALEXION PHARMACEUTICALS
Application Number
EP16195355A
Filing Date
Mar 15, 2007
Status
Granted And Under Opposition
Mar 29, 2024
Publication Date
May 1, 2024
External Links
Slate, Register , Google Patents